InterventionsHumans

Clinical outcomes associated with utilization of Glucagon-like Peptide-1 Receptor Agonists in heart failure patients in the United States

AHA Scientific Sessions 2025 Abstract

The paper

Loghin A, Bashir Z, Saxena R et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4369293

doi.org/10.1161/circ.152.suppl_3.4369293

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
ARNI links to lower osteoporosis risk in heart failure
Internal and Emergency Medicine · 4 Oct 2026